Colin Logie
Dr. Colin Logie developed steroid-regulated site-specific DNA recombination for his PhD (1995) at EMBL, Heidelberg. Later on, he went on to engineer nucleosome remodeling assays at UMASS in Worcester in the late nineties and has since then been a group leader at the Nijmegen Centre for Molecular Life Sciences in the Netherlands, studying chromatin.